Chain was delighted at the prospect. It had never occurred to
him that he might get a post in England, and he was preparing to emigrate to
Canada or Australia. He was at that time a young man of twenty-nine, with
black hair, flashing eyes, and an exceptionally lively mind, very different
from the English, who, however, got the impression that he was something of
a genius — and not without reason. It was Sir Frederick Gowland Hopkins who,
struck by his ability, had recommended him to Florey.
Chain went to see Florey, who explained to him the importance
he attached in his department to biochemistry, since all pathological change
rests upon a biochemical phenomenon. He promised Chain a perfectly free hand
and the right to choose his own subject for research. At the same time, he
suggested that he might do worse than investigate the behaviour of a
bacteriolytic substance, lysozyme, which, said he, played a part in
protecting the body against bacteria and, perhaps, gastric ulcers.
In 1936 Chain, in company with a Rhodes Scholar named
Epstein, attacked this problem, together with another — the biochemical
action of snake-venom. The first thing to be decided was whether lysozyme
was really, as Fleming said it was, an enzyme, that is to say, an element
capable by its presence of encouraging certain reactions and breaking down
certain molecules. If the answer to that question should be 'yes', then it
must follow that there must be in the bacterial cell a substrate on which
the product acted, since enzyme and substrate are as closely related as a
lock and its key, which explains the specificity of the enzymes. The result
was positive. Chain was able to extract from the famous yellow coccus (;micrococcus
lysodeikticus) a
substance (a polysaccharid which was broken up by lysozyme and, in this
particular case, acted as the lock.
This piece of work having been carried through successfully,
it seemed natural to go carefully through the 'literature of the subject',
in other words, anything previously published, and to find out what had been
done already in this field. Chain found close on two hundred papers dealing
with antibacterial substances with a microbial origin, some of which had,
like lysozyme, a lytic (or dissolving) action, while others killed this or
that microbe in a different manner. Chain's attention was thus drawn to an
immense field of study — microbial antagonism. Florey and he discussed the
matter.
Of all the papers through which Chain had worked, the most
interesting seemed to him to be the one written by Fleming in 1929 on
penicillin. He learned from it of the existence of a substance 'with
antibacterial properties rich in promise'. It
had this superiority over lysozyme, that it could destroy dangerous microbes
and in addition was, according to Fleming, completely lacking in toxicity.
Continuing his reading, Chain found that a serious attempt had been made to
extract and purify penicillin, which was more than could be said of the
other substances, but that this had come to nothing.
He was ready to continue the attempt, but the necessary
research would be pretty costly, and there was a shortage of funds. Walking
one day with Florey through the lovely University Parks, he asked whether it
might not be possible to get a few thousand dollars from the Rockefeller
Foundation. The Medical Research Council had granted a few small sums, but
these never amounted to more than fifty or a hundred pounds, which were
almost worse than nothing. Florey forwarded the request and some time later
informed Chain that if a programme of interesting biochemical research were
submitted, the money would probably be forthcoming. Chain said that nothing
would be easier and at once drew up for the Rockefeller Foundation a
memorandum in which he suggested three subjects of study: snake-poison; the
spreading factors; and bacterial
antagonism. There was enough material in these to provide work for ten
years.
Florey approved the memorandum and after a delay of a few
months went in high spirits to tell Chain that a subsidy of five thousand
dollars had been granted by the Foundation. This was marvellous news. The
biochemical laboratory would no longer be prevented for want of a
ridiculously small sum of money from buying the necessary equipment. Chain
began his experiments on penicillin at the beginning of 1939. Then he went
to Belgium for a holiday and, when he got back, war was just about to be
declared.
Why had he started with penicillin? Florey and Chain had
decided that three types of substance should be studied: an enzyme,
pyocyanase; the antibacterial substances produced by the actinomycetes
(which were later to give birth to such powerful antibiotics as
streptomycin, etc.); and penicillin. The latter had many advantages over the
others. It had already been studied under several aspects: it was known to
be non-toxic and finally, though it could be neither conserved nor purified,
it could at least be easily produced.
The Dunn School possessed a strain. How this came about must
be explained. When Chain had arrived in Oxford in 1935, he had come across a
colleague in one of the corridors carrying several Roux bottles containing a
mould. At the time he had not paid much attention to this, but when he came
to read Fleming's paper he realized that the culture he had seen in the
hands of his colleague might perhaps have had something to do with
penicillin.
He went and asked her whether this was so. She explained that
she had been one of Dreyer's assistants: that Dreyer, Florey's predecessor,
had been interested in the bacteriophages, forms of virus capable of
destroying bacteria, and had thought that penicillin might be one of them.
He had asked Fleming to send him a culture of penicillium and this Fleming,
always pleased to find anyone interested in it, had done. Dreyer had soon
seen that penicillin was not a phage,
but had kept it with a view to further work. Chain, in his turn, asked for
the culture.
At that time he knew nothing about moulds, and had to learn
how to handle these extremely temperamental colonies. It seemed impossible
to get any constant results. Sometimes the penicillium gave penicillin,
sometimes it did not. The reason was that Fleming's strain had produced
numerous mutations. Chain verified that the antibacterial substance was
highly unstable, but this very instability aroused his curiosity. The
chemists who before him had tried to extract pure penicillin had reached the
conclusion that 'the substance vanished almost while you looked at it.'
Chain set himself the task of finding the reason for this instability and
attacked the problem by the very much gentler methods of the chemistry of
enzymes, which he knew well.
It was agreed that Florey should carry out biological tests
on the substance when Chain had managed to isolate it and to elucidate its
structure. Chain himself undertook to work on penicillin, and asked one of
his colleagues, Mrs Schoental, to proceed with the study of the pyocyanase.
Chain thought that penicillin must be an unstable enzyme. It
is a known fact that the enzymes in solution often lose their activity when
concentrated by evaporation, because the inactivating substances axe
concentrated at the same time as the enzyme and destroy it. But Chain had at
his disposal a new method which had been developed since the time of the
researches made by Ridley and Raistrick — lyophilization (freeze-drying),
which was being much used in, for example, the conservation of blood-plasma.
The process is very simple and is based on the principle that
when liquids become congealed in a vacuum they pass straight from the solid
to the gaseous state. This phenomenon can be observed on the tops of high
mountains, where ice is sublimated (transformed into vapour) without going
through the intermediate stage of melting. Now if a liquid solution
containing different substances becomes congealed, these substances, when
solidified, cease to have any action on one another (<corpora
non agunt nisi fluida). If,
therefore, the liquid is eliminated by sublimation, the solid substances
which form the dry residue retain their activity almost indefinitely. Here
was a way in which penicillin could be saved.
By freeze-drying the culture-liquid, Chain obtained a brown
powder which contained, together with penicillin, several impurities
(proteins, salts), and consequently could not be used for purposes of
injection. Could one, as his predecessors had hoped, extract penicillin by
dissolving it in pure alcohol? He tried the experiment, but without success.
This did not surprise him, because he believed it to be an enzyme, and,
therefore, not soluble in alcohol. All the same, so as to leave no stone
unturned, he tried again, this time with methyl-alcohol (or methanol) and to
his amazement succeeded. Some part of the impurities was thus eliminated.
Unfortunately, however, the volatile penicillin, when dissolved in methanol,
once again became unstable. The cure for this was to dilute the solution
with water, and then have further recourse to freeze-drying.
Now that he had in his possession a partially purified
penicillin, Chain was eager to test it. Since Florey was just then much
occupied with other research-work, he turned to a great Spanish surgeon,
Joseph Trueta, who happened to be working at the Dunn School on the floor
above, with a young English assistant, John Barnes. At Chain's request,
Barnes injected thirty milligrams of concentrated penicillin into the vein
of a mouse. To the delight of Chain and to the surprise of Trueta, who was
watching the experiment, no toxic reaction occurred.
Florey, much interested, at once repeated the experiment on
another mouse, with a dose of twenty milligrams, and again there was no
toxic effect. He, too, was so completely surprised, that he feared he might
have missed the vein and said to Chain: 'Let me have another dose' —
by no means an easy thing to do at that time. With the utmost difficulty
Chain managed to get hold of the twenty milligrams required and once more
Florey established the non-toxicity of the substance.
So, at last, the Oxford scientists had in their hands, in a
concentrated state, stable and partially purified, a product which possessed
the astonishing property of killing microbes but not the cells of the body.
Florey asked Chain to enlist the help of Heatley, a young and inventive
laboratory-worker who had just come back from Copenhagen, and together he
and Chain perfected a practical method of purifying penicillin.
It would take too long to describe here the innumerable
difficulties which they encountered. The essential points which emerged from
their researches were the following: (i) the work must be done (a), at a low
temperature, and (b) with a neutral pH; and (2) the neutral liquid solution
must be freeze-dried in order to obtain a penicillin salt in powdered form.
It is important to note that the method thus perfected was the one used by
all the big industrial producers until 1946. Without freeze-drying it would
have been impossible to manufacture penicillin on a large scale. Chain had
been among the first to employ this process when he was studying the
enzymes.
In order to measure the antibacterial power of penicillin,
Heatley at first used Fleming's method (holes made in the agar of a Petri
dish and filled with penicillin round which the vulnerable microbes
disappeared). Then he substituted for the holes small glass or porcelain
cylinders planted in the surface of the agar. His first experiments proved
that the product, when partially purified, was a thousand times more active
than the crude penicillin, and ten times more active than the most active of
the sulphonamides. (When completely purified, penicillin turned out to be a
thousand times more active than Chain's first samples and, therefore, a million times
more so than Fleming's crude substance.)
Florey and his colleagues had tested the toxicity of
penicillin given intravenously in a single injection. This Fleming had also
done with his crude penicillin. But now, with most of the proteins removed
and with the substance at last stable, the Oxford team could go farther.
They proceeded to treat rats with an intramuscular injection of ten
milligrams every three hours over a period of fifty-six hours. Once again
there was no accident. They tried the action of their substance on the
arterial pressure and the respiration of cats. They repeated Fleming's
experiments on the leucocytes. 'From all these tests', they tell us, 'it was
clear that this substance possessed qualities which made it suitable for
trial as a chemotherapeutic agent.'
The moment had now come for the crucial test. It was made on
May 25th, 1940, on three groups of mice infected, respectively, with
staphylococci, streptococci and Clostridium
septicum.
Heatley remembers with emotion the night he spent in the laboratory
observing the reactions of the animals, and his joy when he saw the controls
die one after the other, while the treated mice survived. Next morning
Florey and Chain went to ascertain the results. Chain's eyes still sparkle
when he speaks of the occasion.
June 1940 — it was the time of the great German offensive ...
and Dunkirk. Was England going to be invaded? The Oxford team had decided
that, should there be an invasion, they must at all costs save the
miraculous mould the importance of which could no longer be doubted. They
soaked the linings of their clothes in the brown liquid. It would be enough
if only one of them escaped, for he would have on his person spores enough
with which to start new cultures. By the end of the month they had enough
penicillin for a decisive experiment. This was carried out on July 1st, on
fifty white mice. All of them were given a more than lethal injection of
virulent streptococci — I c.c. Twenty-five served as controls. The other
twenty-five were treated with penicillin every three hours over a period of
two days and two nights. Florey and his assistant, Kent, slept in the
laboratory and were aroused by an alarm-clock every two hours. At the end of
sixteen hours the twenty-five control mice were dead. Twenty-four of the
treated mice survived the experiment.
The results smacked of the miraculous. They were set down in
sober black and white in a note published by the Lancet.l The
signatories were Florey, Chain and Heatley who had done the extracting and
conducted the first tests on animals. To their names were added those of
Jennings, Orr-Ewing, Sanders and Gardner, whose help Florey had enlisted for
the purpose of studying the miraculous substance more thoroughly. Gardner
supplied the bacteriological study, confirmed Fleming's results and added
some microbes to the list of those on which penicillin had an effect, in
particular, that of gas-gangrene which in time of war was of paramount
importance.
These names accounted for all but one of the Oxford team.
Fleming had never had so large a group of specialists working with him. For
this discovery to come about, first and foremost the solitary worker had
been necessary, and only after him, following on his heels, the team. 'The
work of a team', Chain has written, eis
important for the development of an idea already formulated, but I do not
believe that a team has ever produced a new idea.' And Fleming: Tor the
birth of something new, there has to be a happening. Newton saw an apple
fall; James Watt watched a kettle boil; Roentgen fogged some photographic
plates. And these people knew enough to translate ordinary happenings into
something new ...'
When Fleming read in the Lancet the
first communication made by the Oxford team, he had the happiest surprise of
his life. He had always known, and had never tired of saying, that a day
would come when penicillin would be concentrated and purified, and that then
it would be possible to use it in the treatment of generalized infections.
He had but one thought — to see his darling substance in its pure state.
He therefore went to Oxford to see Florey and Chain. The
latter was taken completely by surprise: he had thought that Fleming was
dead! 'He struck me', he says, 'as a man who had difficulty in expressing
himself, though he gave the impression of being somebody with a very warm
heart doing all he could to appear cold and distant.' The truth was that he
was making a great effort to conceal his joy, for he had always made it a
rule never to show his feelings. 'You have made something of my substance,'
was all he said to Chain. Craddock who saw him on his return relates that,
speaking of the Oxford team, he said: 'They have turned out to be the
successful chemists I should have liked to have with me in 1929.'
Fleming to Florey, November 15th, 1940 Dear
Florey,
I am sorry to have been so long in sending you cultures of
the penicillium which did not produce much yellow colour. When I got back
from visiting you, I planted out a large number of my old cultures in broth,
and I have selected from these a number which, while producing a good yield
of penicillin, did not appreciably colour the broth yellow. I am sending
these on to you, and I hope you will find them useful.
I have been comparing the solid penicillin which I got from
you with the sulphonamides and it seems to be, weight for weight, a great
deal more potent than the most powerful of those on the ordinary septic
microbes.
It only remains for your chemical colleagues to purify the
active principle, and then synthesize it, and the sulphonamides will be
completely beaten.
Yours sincerely
alexander fleming
Dr E. W. Todd to Fleming, August 23rd, 1940
London County Council, Public Health Dept, Belmont
Laboratories, Stanley Road, Sutton, Surrey
My Dear Flem,
I was delighted to read in the Lancet this
morning about penicillin. When can we start production? I am laboriously
making gas-gangrene
anti-toxin>
and penicillin sounds
much simpler.
I can claim to have been in the same room when you made the
great discovery. Do you think that there is any chance that I might get a
knighthood on that claim when you are raised to the Peerage?
Are you producing penicillin for therapeutic use?
Congratulations,
Yours ever
e.
W. t.
The time had now come to try penicillin on human patients,
but that would need great quantities of penicillin in as pure a state as
possible. The substance to be dealt with was a madly temperamental mould and
it was essential to move quickly. Heatley gave himself to the problem of
extracting the product; Chain and Abraham concentrated on its purification.
To describe here all their difficulties and disappointments would involve
too many technical explanations. But it can and should be said that they
showed admirable qualities of ingenuity and tenacity. The group met every
day at tea-time, recorded their failures, deplored them, but never showed
discouragement. The stake was well worth the trouble taken.
After innumerable washings, manipulations and filterings,
they at last obtained a yellow powder which was a salt of barium containing
about five hundred units of penicillin per milligram.2At
first, the percentage of penicillin, for the same weight, had been half a
unit. This was an excellent result. Next, the yellow pigment had to be
precipitated. The final stage of the operation, the evaporation of the water
in order to obtain a dry powder, still presented difficulties. The normal
method of turning water into steam is to make it boil: but heat destroys
penicillin. They had to have recourse to the other method, which consists of
reducing the pressure above the water and so lowering the boiling-point. The
use of a vacuum pump made it possible to evaporate the water at a very low
temperature. The precious yellow powder remained at the bottom of the jar.
It felt to the touch like cornflour. This penicillin was still only half
pure. Nevertheless, when Florey made his bacteriological tests, he found
that a thirty-millionth solution of this powder was enough to inhibit the
development of the staphylococci.
The most convincing case would have been one of septicaemia.
But this presented certain difficulties. On the one hand, the quantity of
penicillin available did not permit the injection of a massive dose; on the
other, the rapid excretion of the product would mean that it would remain in
the body for an insufficient length of time. It was very quickly eliminated
by the kidneys. No doubt it would be found in the urine and could be
extracted and used again. But these operations would be lengthy, and the
patient would have plenty of time in which to die. Giving the product by the
mouth would be ineffective, because the gastric juices would destroy the
penicillin as soon as it reached the stomach. What appeared to be desirable
was the maintenance in the blood stream, by successive injections, of a
quantity of the substance sufficient to allow the natural defence mechanisms
of the body to destroy the microbes which, thanks to the penicillin, would
have become far less numerous. The best method, therefore, would be frequent
injections, or perhaps, even, intravenous drip.
The inadequate quantities on hand increased the natural
anxiety always aroused by any brand-new experiment on a patient. There was
the risk that a treatment might be begun which could not be continued.
Florey went to see the directors of a great industry specializing in
chemical products, told them that he had in his hands a substance which
looked as though it would turn out to be a miraculous remedy, and asked,
without concealing from them the difficulties of the enterprise, whether
they were prepared to undertake its production on a large scale. After
thinking the suggestion over, these industrial chemists refused. They are
not to be blamed. Their factories were fully occupied by Government orders
for war-material; the methods perfected, with the greatest difficulty, by
the Oxford team, would have involved an enormous amount of work; and, last
but not least, the concern would have run the risk, after equipping their
factories at great expense, of seeing some research-worker suddenly solve
the problem of making synthetic pencillin and so drastically reducing the
cost of production.
The only thing left for the Oxford chemists to do was once
again to work with such means as they could find ready to hand. The task
given by Florey to Heatley was to produce a hundred litres of culture a week
and to extract the penicillin. A small quantity of the yellow powder was put
aside in a refrigerator for emergencies at the beginning of February 1941.
At that very moment a case turned up which, because it seemed desperate,
justified the carrying through of a daring experiment. A policeman in Oxford
was dying of septicaemia. It had started with a small infected scratch at
the corner of the mouth. Then the whole blood-content of the body had been
poisoned. The microbe in question was the staphylococcus
aureus,
which is vulnerable to penicillin. The patient had been treated
unsuccessfully with sulphonamides. There were abscesses all over his body
and his lungs had been affected. The doctors regarded his condition as
hopeless. If penicillin resulted in a cure, it would be a shattering proof
of its power.
On February 12th, 1941, an intravenous injection of a00 mg.
of penicillin was given to the dying man and, thereafter, an injection of
100 mg. every three hours. At the end of twenty-four hours the improvement
in his condition was startling. The wounds had ceased to suppurate. It was
obvious that the patient, only the day before at the point of death, was now
well on the way to recovery. While continuing the penicillin injections, the
doctors gave him a blood-transfusion. Unfortunately, the tiny reserve of
yellow powder was dwindling in a tragic fashion. It was possible to recover
a certain amount from the man's urine and the improvement became still more
marked. The patient felt better. He was eating. His temperature had dropped.
Two facts in painful contrast to each other were now only too obvious. The
penicillin treatment, if it could be maintained, would undoubtedly save his
life, but it could not be continued long enough because there would not be
sufficient penicillin available. Heatley worked devotedly, but he could only
wait until the cultures had produced a fresh crop. He very soon had to stop
the injections. The patient managed to hold on for a few days. But the
microbes, being no longer attacked, got the upper hand and, on March 15th,
the policeman died.
Florey now knew that
if he had had enough penicillin, the man could have been saved. But he could
not prove a
hypothetical success. A transfusion had been given and it was open to
sceptical critics to say that the improvement had been due to that. The
first test, therefore, had partially failedw The yellow powder, fruit of so
much hard work, had been used in vain. The Oxford team was saddened but not
discouraged. When a new supply of penicillin was ready, three other cases
were treated. All of them gave evidence of the immediately beneficial and
spectacular action of the substance. Two of the cases were completely cured.
The third, that of a child who had been brought out of a coma by penicillin,
was getting much better, when death supervened as the result of the
accidental rupture of a blood-vessel. But even severe judges could no longer
doubt that medicine now possessed a new chemotherapeutic product of
unparalleled strength, which was non-toxic. The first patient, when
injected, had had a sharp rise in temperature and a rigor, but this was due
to certain impurities still remaining in the drug, and was not repeated when
penicillin had been completely purified.
Was it possible that on the strength of these first results
the British Government would set on foot an immense effort to manufacture
the miraculous remedy on an industrial scale? Florey very quickly realized
that the answer to that question would be in the negative. England in 1941
was suffering under incessant bombing raids. It was conducting, or
preparing, a war on all fronts. Urgent day-to-day necessities took priority
over everything else. The men and women who were living under the constant
threat of seeing their homes reduced to ruins on top of them could scarcely
be expected to regard the war against microbes as a matter of essential
importance. But Florey could measure the effects of a massive employment of
penicillin and envisage the consequences for the wounded and for the
war-effort as a whole.
The Oxford scientists approached nearly all the major
manufacturers of chemical products. The reply in almost every case was the
same: 'Yes, Doctor,
you have made a most important discovery, but the production of your
substance on a commercial scale is impossible because your output is too
small.' The treatment of a single case needed thousands of litres of
cultures. The proposition was not a practical one. The obvious remedy for
this state of affairs was an increase in output and the financing of a vast
research programme. But the English factories, under the harsh conditions of
war, were in no state to make the necessary effort. The only alternative was
to turn to America.
Florey and Heatley left for the United States via Lisbon in
June 1941, taking with them some strains of penicillium. The heat was
intense and they were in a condition of the most extreme anxiety throughout
the voyage, since the precious moulds could not stand high temperatures. In
New York, Florey renewed acquaintance with an American friend who at once
put him on the track of the man who could get things moving, Charles Thorn,
who had identified the penicillium
notatum,
and was now Head of the Mycological Section of the Northern Regional
Research Laboratory at Peoria, Illinois. This laboratory had been created to
make research into the utilization of the organic by-products of agriculture
which were polluting the rivers of the Middle West. The intention was to
convert these waste products into usable fermentations, and the chemists
there had been concentrating their efforts on producing gluconic acid by
using the fermentation powers of moulds of the penicillium
chrysogenum type.
In this work they had been using, as their source of nitrogen, corn steep
liquor, a by-product of the manufacture of starch from maize. This liquor
had accumulated in the region to an embarrassing extent. The chemists had
succeeded in making the gluconic acid production work by using a method of
submerged fermentation.
Florey passed from scientist to scientist and finally reached
Dr Coghill, who was Chief of the Division of Fermentation at Peoria. To him
he explained his problem. It should be mentioned that the English scientists
(and this is as true of Fleming as of Florey, of Chain as of Heatley) had
done nothing to protect their discoveries by taking out a patent. In their
eyes a substance which could render such services to mankind ought not to
become a source of private profit. So extreme a degree of disinterestedness
deserves to be stressed and applauded. They gave to the Americans all the
results of their prolonged researches and all their methods of manufacture,
asking in return only for penicillin so as to be able to continue their
medical experiments.
Heatley stayed on in Peoria to take part in the work. The
first objective was to increase output, which meant finding a favourable
medium for the penicillium culture. The Americans suggested corn steep
liquor with which they were familiar and which they had used as a medium for
similar cultures. They quickly obtained an output twenty times higher than
that of Oxford and this brought them within sight of a practical solution of
the problem. It would be possible, at least for war purposes, to produce
penicillin in quantity. The substitution of lactose for glucose still
further improved the output.
Once again we are left wondering at the curious operations of
Chance. If the Americans had not been embarrassed by an excessive
accumulation of their steepiiig liquor, they would not have set up a
laboratory at Peoria. Had it not existed, no one would have hit upon that
particular culture medium — maize-liquor + lactose — and the commercial
production of penicillin might have been indefinitely postponed. On the
other hand, the arrival of the scientists from England had alone made it
possible for this laboratory to do the work for which it had been set up,
since the making of gluconic acid would not of itself have absorbed the
immense quantities of corn steep liquor available, whereas the manufacture
of penicillin would very soon make it extremely precious and increase its
value a hundred times.
The new culture medium was not the only contribution made by
Peoria, The mycologists attached to the laboratory were looking for
mould-strains which would give a larger yield of penicillin, for it is a
curious fact that all the cultures so far made in England and America were
descended from the same spore, the one which had landed on Fleming's
work-bench. Up till 1943, nothing better had been found, though a great many
strains had been tried. It was most unlikely that this particular strain,
which had not been deliberately chosen, should turn out to be the best. The
American research-workers had enlisted the help of the Army authorities in
getting specimens of moulds from all over the world, but none had proved to
be usable. But the laboratory had also taken on a young woman whose function
it was to go to market and buy every variety of mould she could find. She
was very soon known as 'Mouldy Mary'. One day she returned from market with
a mould of the penicillium
chrysogenum type
which she had found growing in a cantaloup melon which had gone bad. It
showed itself to be remarkably productive. The application of genetic
methods improved its yield still further, and most of the strains used today
(after mutations) come from the rotten Peoria melon. The scientists, as so
often happens, had on their doorstep what they had been searching for in
vain all over the world.
While Heatley was working with the chemists at Peoria, Florey
started on a pilgrimage which was to take him all over America and Canada,
visiting numerous factories turning out chemical products and trying to
interest industrialists in the production of penicillin on a really great
scale. The situation in America seemed to be less difficult than it was in
England. In early 1941 the country was still not yet at war. But it was
receiving a considerable number of orders, and most of the industrial
leaders whom Florey saw showed only moderate enthusiasm for an enterprise
which they regarded as both uncertain and difficult. All the same, many of
them expressed their good will and, when Florey left for England, he took
with him promises from two firpls, each of which had undertaken to produce
ten thousand Utr^s and to send the penicillin to Oxford for purposes of
medical research. His last visit was to his friend Dr A. N. Richards whom he
had known formerly at the University of Pennsylvania. Dr Richards had just
been appointed President of the Committee of Medical Research. This
important post would give him considerable influence and make it possible
for him to interest the American Government in penicillin. The journey had
been productive of great results.